Plain-English translation of NCT06984185 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes research guide →This trial is testing whether a combined autoantibody blood test performed on a small sample from a finger prick—collected on blotting paper like newborn screening—works as well as traditional venous blood tests for detecting type 1 diabetes in children. Researchers want to validate this simpler method so it can eventually be used to catch type 1 diabetes very early, even before symptoms appear, in children at risk.
Right now, doctors use needle blood draws to test for type 1 diabetes antibodies, which are harder to do at home or in routine checkups. This trial exists to prove that a finger-prick test on blotting paper is just as accurate, which would make early screening much easier and more accessible for families.
You likely qualify if…
You likely don't qualify if…
If you join, you will have a finger-prick blood sample collected on blotting paper, similar to newborn screening. At the same time, you'll also have a traditional venous blood draw so researchers can compare both methods. This allows them to confirm that the simpler finger-prick test gives the same accurate results as the standard test.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
France
Enrollment target
~106 participants
Started
November 2025
Primary completion
December 2026
Age range
1 Year – 18 Years
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Kevin PERGE, Dr
Hospices Civils de Lyon
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.